U.S. markets closed
  • S&P 500

    3,768.25
    -27.29 (-0.72%)
     
  • Dow 30

    30,814.26
    -177.24 (-0.57%)
     
  • Nasdaq

    12,998.50
    -114.10 (-0.87%)
     
  • Russell 2000

    2,123.20
    -32.15 (-1.49%)
     
  • Crude Oil

    52.29
    -0.07 (-0.13%)
     
  • Gold

    1,836.60
    +6.70 (+0.37%)
     
  • Silver

    25.21
    +0.34 (+1.38%)
     
  • EUR/USD

    1.2099
    +0.0016 (+0.13%)
     
  • 10-Yr Bond

    1.0970
    -0.0320 (-2.83%)
     
  • GBP/USD

    1.3603
    +0.0016 (+0.12%)
     
  • USD/JPY

    104.0530
    +0.3660 (+0.35%)
     
  • BTC-USD

    36,652.93
    -286.67 (-0.78%)
     
  • CMC Crypto 200

    720.00
    -15.14 (-2.06%)
     
  • FTSE 100

    6,720.65
    -15.06 (-0.22%)
     
  • Nikkei 225

    28,603.85
    +361.64 (+1.28%)
     

Can You Imagine How Magellan Health's (NASDAQ:MGLN) Shareholders Feel About The 40% Share Price Increase?

Simply Wall St
·3 min read

If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share price move up more than the market average. But Magellan Health, Inc. (NASDAQ:MGLN) has fallen short of that second goal, with a share price rise of 40% over five years, which is below the market return. Over the last twelve months the stock price has risen a very respectable 8.1%.

View our latest analysis for Magellan Health

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

During the five years of share price growth, Magellan Health moved from a loss to profitability. That's generally thought to be a genuine positive, so we would expect to see an increasing share price.

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

earnings-per-share-growth
earnings-per-share-growth

We like that insiders have been buying shares in the last twelve months. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. This free interactive report on Magellan Health's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

A Different Perspective

Magellan Health shareholders are up 8.1% for the year. But that was short of the market average. On the bright side, that's still a gain, and it's actually better than the average return of 7% over half a decade This suggests the company might be improving over time. It's always interesting to track share price performance over the longer term. But to understand Magellan Health better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 2 warning signs with Magellan Health , and understanding them should be part of your investment process.

Magellan Health is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.